Barrett, Frederick S.

Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder: A Randomized Clinical Trial

Davis, A. K., Barrett, F. S., May, D. G., Cosimano, M. P., Sepeda, N. D., Johnson, M. W., Finan, P. H., & Griffiths, R. R. (2021) · JAMA Psychiatry

Psychedelics and Drug StudiesTreatment of Major Depression

Cited by 1,301

Validation of the revised Mystical Experience Questionnaire in experimental sessions with psilocybin

Barrett, F. S., Johnson, M. W., & Griffiths, R. R. (2015) · Journal of Psychopharmacology

Psychedelics and Drug StudiesParanormal Experiences and Beliefs

Cited by 637

Music-evoked nostalgia: Affect, memory, and personality

Barrett, F. S., Grimm, K. J., Robins, R. W., Wildschut, T., Sedikides, C., & Janata, P. (2010) · Emotion

Nostalgia and Consumer BehaviorMemory Processes and Influences

Cited by 547

Psilocybin-occasioned mystical-type experience in combination with meditation and other spiritual practices produces enduring positive changes in psychological functioning and in trait measures of prosocial attitudes and behaviors

Griffiths, R. R., Johnson, M. W., Richards, W. A., Richards, B. D., Jesse, R., MacLean, K. A., Barrett, F. S., Cosimano, M. P., & Klinedinst, M. A. (2018) · Journal of Psychopharmacology

Psychedelics and Drug StudiesReligion, Spirituality, and Psychology

Cited by 520

Classic psychedelics: An integrative review of epidemiology, therapeutics, mystical experience, and brain network function

Johnson, M. W., Hendricks, P. S., Barrett, F. S., & Griffiths, R. R. (2019) · Pharmacology & Therapeutics

Psychedelics and Drug StudiesParanormal Experiences and Beliefs

Cited by 506

Efficacy and safety of psilocybin-assisted treatment for major depressive disorder: prospective 12-month follow-up.

Gukasyan, N., Davis, A. K., Barrett, F. S., Cosimano, M. P., Sepeda, N. D., Johnson, M. W., & Griffiths, R. R. (2022) · Journal of Psychopharmacology

Psychedelics and Drug StudiesTreatment of Major Depression

Cited by 425

Emotions and brain function are altered up to one month after a single high dose of psilocybin.

Barrett, F. S., Doss, M. K., Sepeda, N. D., Pekar, J. J., & Griffiths, R. R. (2020) · Scientific Reports

Psychedelics and Drug StudiesNeurotransmitter Receptor Influence on Behavior

Cited by 375

Psychological flexibility mediates the relations between acute psychedelic effects and subjective decreases in depression and anxiety

Davis, A. K., Barrett, F. S., & Griffiths, R. R. (2020) · Journal of Contextual Behavioral Science

Psychedelics and Drug StudiesMindfulness and Compassion Interventions

Cited by 375

The Challenging Experience Questionnaire: Characterization of challenging experiences with psilocybin mushrooms

Barrett, F. S., Bradstreet, M. P., Leoutsakos, J.-M. S., Johnson, M. W., & Griffiths, R. R. (2016) · Journal of Psychopharmacology

Psychedelics and Drug StudiesParanormal Experiences and Beliefs

Cited by 366

Psilocybin therapy increases cognitive and neural flexibility in patients with major depressive disorder

Doss, M. K., Považan, M., Rosenberg, M. D., Sepeda, N. D., Davis, A. K., Finan, P. H., Smith, G. S., Pekar, J. J., Barker, P. B., Griffiths, R. R., et al. (2021) · Translational Psychiatry

Psychedelics and Drug StudiesTreatment of Major Depression

Cited by 356

Classic Hallucinogens and Mystical Experiences: Phenomenology and Neural Correlates

Barrett, F. S., & Griffiths, R. R. (2017) · Current Topics in Behavioral Neurosciences

Psychedelics and Drug StudiesParanormal Experiences and Beliefs

Cited by 273

Development of the Psychological Insight Questionnaire among a sample of people who have consumed psilocybin or LSD

Davis, A. K., Barrett, F. S., So, S., Gukasyan, N., Swift, T. C., & Griffiths, R. R. (2021) · Journal of Psychopharmacology

Psychedelics and Drug StudiesParanormal Experiences and Beliefs

Cited by 169

Double-blind comparison of the two hallucinogens psilocybin and dextromethorphan: effects on cognition

Barrett, F. S., Carbonaro, T. M., Hurwitz, E., Johnson, M. W., & Griffiths, R. R. (2018) · Psychopharmacology

Psychedelics and Drug StudiesSchizophrenia research and treatment

Cited by 109

Neuroticism is associated with challenging experiences with psilocybin mushrooms

Barrett, F. S., Johnson, M. W., & Griffiths, R. R. (2017) · Personality and Individual Differences

Psychedelics and Drug StudiesParanormal Experiences and Beliefs

Cited by 98

Optimal dosing for psilocybin pharmacotherapy: Considering weight-adjusted and fixed dosing approaches

Garcia-Romeu, A., Barrett, F. S., Carbonaro, T. M., Johnson, M. W., & Griffiths, R. R. (2021) · Journal of Psychopharmacology

Psychedelics and Drug StudiesTreatment of Major Depression

Cited by 96

Effects of Setting on Psychedelic Experiences, Therapies, and Outcomes: A Rapid Scoping Review of the Literature

Golden, T. L., Magsamen, S., Sandu, C. C., Lin, S., Roebuck, G. M., Shi, K. M., & Barrett, F. S. (2022) · Current Topics in Behavioral Neurosciences

Psychedelics and Drug StudiesArt Therapy and Mental Health

Cited by 85

The therapeutic alliance between study participants and intervention facilitators is associated with acute effects and clinical outcomes in a psilocybin-assisted therapy trial for major depressive disorder

Levin, A. W., Lancelotta, R., Sepeda, N. D., Gukasyan, N., Nayak, S., Wagener, T. L., Barrett, F. S., Griffiths, R. R., & Davis, A. K. (2024) · PLoS ONE

Psychedelics and Drug StudiesPsychotherapy Techniques and Applications

Cited by 82

Brain-based correlates of antidepressant response to ketamine: a comprehensive systematic review of neuroimaging studies

Medeiros, G. C., Matheson, M., Demo, I., Reid, M. J., Matheson, S., Twose, C., Smith, G. S., Gould, T. D., Zarate, C. A., Barrett, F. S., et al. (2023) · The Lancet Psychiatry

Treatment of Major DepressionElectroconvulsive Therapy Studies

Cited by 49